Clinical Trials Browser

Unknown × Melanoma × 130-nm albumin-bound paclitaxel × Clear all

NCT04979585 2021-08-03

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

Phase 2 Unknown

Melanoma